April 25, 2018 / 12:10 PM / 7 months ago

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

April 25 (Reuters) - Chembio Diagnostics Inc:

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

* CHEMBIO DIAGNOSTICS INC - WILL RECEIVE FUNDING FROM LUMIRADX, SUBJECT TO CERTAIN MILESTONES, TO DEVELOP CERTAIN NEW POC INFECTIOUS DISEASE TESTS

* CHEMBIO DIAGNOSTICS INC - AGREEMENT INCLUDES POTENTIAL DEVELOPMENT OF A VARIETY OF NEW POC TESTS

* CHEMBIO DIAGNOSTICS - FOLLOWING REGULATORY APPROVAL, COMMERCIALIZATION, CO WILL SELL REAGENTS TO, RECEIVE ROYALTY PAYMENTS FROM, LUMIRADX ON SALES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below